UPXI (STOCKS)
Upexi, Inc. Common Stock
$0.783900
-0.039700 (-4.82%)
Prev close: $0.823600
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Allan Marshall
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $61.87M
- Employees
- 59
- P/E (TTM)
- -0.20
- P/B (TTM)
- -1.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q3)
|
$-1.67 | $-0.20 | -1.4660 | -718.63% |
|
Dec 2025 (Q2)
|
$-2.94 | $-0.05 | -2.8890 | -5,664.71% |
|
Sep 2025 (Q1)
|
$-1.67 | $-0.20 | -1.4660 | -718.63% |
|
Jun 2025 (Q4)
|
$-2.94 | $-0.05 | -2.8890 | -5,664.71% |
Financial Statements
| Revenues | $26.14M |
| Benefits Costs and Expenses | $254.58M |
| Cost Of Revenue | $3.39M |
| Costs And Expenses | $254.58M |
| Gross Profit | $22.75M |
| Nonoperating Income/Loss | -$8.95M |
| Operating Expenses | $242.25M |
| Depreciation and Amortization | $457.35K |
| Other Operating Expenses | $241.79M |
| Operating Income/Loss | -$219.50M |
| Income/Loss From Continuing Operations After Tax | -$228.45M |
| Income/Loss From Continuing Operations Before Tax | -$228.45M |
| Income Tax Expense/Benefit | $13.56K |
| Interest Expense, Operating | $77.37K |
| Net Income/Loss | -$228.45M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$228.45M |
| Net Income/Loss Available To Common Stockholders, Basic | -$228.45M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.59 |
| Diluted Earnings Per Share | $0.53 |
| Basic Average Shares | 130,365,224 |
| Diluted Average Shares | 130,365,224 |
| Assets | $200.37M |
| Current Assets | $121.80M |
| Accounts Receivable | $400.00K |
| Inventory | $215.24K |
| Other Current Assets | $121.19M |
| Noncurrent Assets | $78.57M |
| Fixed Assets | $241.22K |
| Intangible Assets | $855.54K |
| Other Non-current Assets | $77.47M |
| Liabilities | $252.29M |
| Current Liabilities | $70.82M |
| Accounts Payable | $288.72K |
| Other Current Liabilities | $70.53M |
| Noncurrent Liabilities | $181.47M |
| Equity | -$51.92M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$51.92M |
| Liabilities And Equity | $200.37M |
| Net Cash Flow From Operating Activities | -$21.52M |
| Net Cash Flow From Operating Activities, Continuing | -$21.52M |
| Net Cash Flow From Investing Activities | -$134.00M |
| Net Cash Flow From Investing Activities, Continuing | -$134.00M |
| Net Cash Flow From Financing Activities | $158.78M |
| Net Cash Flow From Financing Activities, Continuing | $158.78M |
| Net Cash Flow | $3.25M |
| Net Cash Flow, Continuing | $3.25M |
| Comprehensive Income/Loss | -$228.45M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$228.45M |
| Other Comprehensive Income/Loss | $0.00 |